Dr. med. Katrin Gade

 
Staff Status
unigoe
 

1-26 of 26
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2020 Journal Article | 
    ​ ​Comes AL, Czamara D, Adorjan K, Anderson-Schmidt H, Andlauer TFM, Budde M, et al. ​The role of environmental stress and DNA methylation in the longitudinal course of bipolar disorder​. ​​International Journal of Bipolar Disorders. ​2020;​8​(1). ​doi:10.1186/s40345-019-0176-6. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Dwyer D, Kalman J, Budde M, Kambeitz J, Ruef A, Kambeitz-Ilankovic L, et al. ​F65. AN INVESTIGATION OF TRANSDIAGNOSTIC PSYCHOSIS SUBGROUPS WITH PROGNOSTIC AND GENETIC VALIDATION​. ​​Schizophrenia Bulletin. ​2019;​45​(Supplement_2):​​S279​-S280​. ​doi:10.1093/schbul/sbz018.477. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Papiol S, Just D, Kannaiyan N, Anderson-Schmidt H, Budde M, Gade K, et al. ​High-Throutghtput Antibody-Based Profiling of Serum in Shiziphrenia and Bipolar Disorder Patients: An Integrative Genomics-Proteomics Pilot Study​. ​​European Neuropsychopharmacology. ​2019;​29​:​​S993​-S994​. ​doi:10.1016/j.euroneuro.2017.08.378. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Adorjan K, Papiol S, Gade K, Malzahn D, Sherva R, Budde M, et al. ​POLYGENIC RISK BURDEN AND CANNABIS USE COMORBIDITY IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER​. ​​European Neuropsychopharmacology. ​2019;​29​:​​S951​. ​doi:10.1016/j.euroneuro.2017.08.302. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Kalman J, Papiol S, Heilbronner U, Andlauer TF, Anderson-Schmidt H, Budde M, et al. ​EFFECTS OF SCHIZOPHRENIA AND BIPOLAR POLYGENIC RISK SCORES ON AGE AT ONSET IN BIPOLAR DISORDER​. ​​European Neuropsychopharmacology. ​2019;​29​:​​S967​. ​doi:10.1016/j.euroneuro.2017.08.331. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Gade K, Papiol S, Heilbronner U, Budde M, Adorjan K, Anderson-Schmidt H, et al. ​THE IMPACT OF BIPOLAR AND SCHIZOPHRENIA POLYGENIC RISK SCORES ON FAMILIAL FEATURES OF BIPOLAR DISORDER​. ​​European Neuropsychopharmacology. ​2019;​29​:​​S968​. ​doi:10.1016/j.euroneuro.2017.08.333. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Schulte E, Kondofersky I, Budde M, Adorjan K, Aldinger F, Anderson-Schmidt H, et al. ​POLYGENIC BURDEN ANALYSIS OF LONGITUDINAL CLUSTERS OF PSYCHOPATHOLOGICAL FEATURES IN A CROSS-DIAGNOSTIC GROUP OF INDIVIDUALS WITH SEVERE MENTAL ILLNESS​. ​​European Neuropsychopharmacology. ​2019;​29​:​​S995​-S996​. ​doi:10.1016/j.euroneuro.2017.08.382. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Budde M, Schaupp SK, Comes AL, Papiol S, Yoshida T, Adorjan K, et al. ​M44 COGNITIVE PERFORMANCE IN THE PSYCOURSE STUDY: THE AFFECTIVE-TO-PSYCHOTIC SPECTRUM AND ITS ASSOCIATION WITH POLYGENIC RISK SCORES FOR SEVERE MENTAL ILLNESSES​. ​​European Neuropsychopharmacology. ​2019;​29​:​​S189​. ​doi:10.1016/j.euroneuro.2019.08.144. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Schulte E, Tkachev A, Adorjan K, Anderson-Schmidt H, Budde M, Gade K, et al. ​96 LIPIDOME ANALYSIS IN INDIVIDUALS WITH SCHIZOPHRENIA REVEALS CHARACTERISTIC PLASMA LIPID PROFILES​. ​​European Neuropsychopharmacology. ​2019;​29​:​​S113​. ​doi:10.1016/j.euroneuro.2019.07.237. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Schaupp S, Budde M, Kondofersky I, Papiol S, Heilbronner U, Gade K, et al. ​F96POLYGENIC RISK SCORE ANALYSIS OF TRAJECTORIES OF COGNITIVE PERFORMANCE IN PSYCHIATRIC PATIENTS​. ​​European Neuropsychopharmacology. ​2019;​29​:​​S1161​. ​doi:10.1016/j.euroneuro.2018.08.176. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Schulte E, Kondofersky I, Budde M, Adorjan K, Aldinger F, Anderson-Schmidt H, et al. ​SA125POLYGENIC BURDEN ANALYSIS OF LONGITUDINAL CLUSTERS OF PSYCHOPATHOLOGICAL FEATURES IN A CROSS-DIAGNOSTIC GROUP OF INDIVIDUALS WITH SEVERE MENTAL ILLNESS​. ​​European Neuropsychopharmacology. ​2019;​29​:​​S1257​-S1258​. ​doi:10.1016/j.euroneuro.2018.08.347. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Comes A, Adorjan K, Andlauer T, Budde M, Degenhardt F, Forstner AJ, et al. ​SU62THE ROLE OF ENVIRONMENTAL STRESS AND DNA METHYLATION IN THE LONGITUDINAL COURSE OF BIPOLAR DISORDER​. ​​European Neuropsychopharmacology. ​2019;​29​:​​S1300​-S1301​. ​doi:10.1016/j.euroneuro.2018.08.426. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Budde M, Gade K, Anderson-Schmidt H, Kalman J, Senner F, Adorjan K, et al. ​SA88PSYCOURSE: A TRANSDIAGNOSTIC STUDY ON THE COURSE OF SEVERE MENTAL DISORDERS​. ​​European Neuropsychopharmacology. ​2019;​29​:​​S1236​. ​doi:10.1016/j.euroneuro.2018.08.310. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Heilbronner U, Wendel B, Budde M, Gade K, Adorjan K, Kalman J, et al. ​SU53A CROSS-DIAGNOSTIC GWAS OF LONGITUDINAL EXECUTIVE FUNCTION PROFILE SCORES​. ​​European Neuropsychopharmacology. ​2019;​29​:​​S1295​-S1296​. ​doi:10.1016/j.euroneuro.2018.08.417. 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Anderson-Schmidt H, Gade K, Malzahn D, Papiol S, Budde M, Heilbronner U, et al. ​The influence of religious activity and polygenic schizophrenia risk on religious delusions in schizophrenia​. ​​Schizophrenia Research. ​2019;​210​:​​255​-261​. ​doi:10.1016/j.schres.2018.12.025. 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​Comes AL, Senner F, Budde M, Adorjan K, Anderson-Schmidt H, Andlauer TFM, et al. ​The genetic relationship between educational attainment and cognitive performance in major psychiatric disorders​. ​​Translational Psychiatry. ​2019;​9​(1). ​doi:10.1038/s41398-019-0547-x. 
    Details  DOI 
  • 2017 Journal Article | 
    ​ ​Bahari-Javan S, Fischer A, Varbanov H, Halder R, Benito-Garagorri E, Kaurani L, et al. ​HDAC1 links early life stress to schizophrenia-like phenotypes​. ​​Proceedings of the National Academy of Sciences of the United States of America. ​2017;​114​(23):​​1​-9​. ​doi:10.1073/pnas.1613842114. 
    Details  DOI  PMID  PMC 
  • 2017 Journal Article
    ​ ​Heilbronner U, Jain G, Kaurani L, Kondofersky I, Budde M, Gade K, et al. ​The Role Of Micrornas In The Course Of Severe Mental Disorders​. ​​European Neuropsychopharmacology. ​2017;​27​:​​456​-457​. ​doi:10.1016/j.euroneuro.2016.09.527. 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Comes A, Aldinger F, Kondofersky I, Adorjan K, Anderson-Schmidt H, Andlauer TF, et al. ​POLYGENIC BURDEN ANALYSIS OF LONGITUDINAL CLUSTERS OF QUALITY OF LIFE AND FUNCTIONING IN PATIENTS WITH SEVERE MENTAL ILLNESS​. ​​European Neuropsychopharmacology. ​2017;​27​:​​S408​-S409​. ​doi:10.1016/j.euroneuro.2016.09.450. 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Adorjan K, Papiol S, Gade K, Malzahn D, Budde M, Aldinger F, et al. ​Polygenic Risk Scores And Substance Abuse Comorbidity In Patients With Schizophrenia And Bipolar Disorders​. ​​European Neuropsychopharmacology. ​2017;​27​:​​S409​. ​doi:10.1016/j.euroneuro.2016.09.451. 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Kalman J, Budde M, Dwyer D, Papiol S, Anderson-Schmidt H, Gade K, et al. ​Using Machine Learning To Build Individualized Prediction Models Of Future Quality Of Life In Psychosis Patients​. ​​European Neuropsychopharmacology. ​2017;​27​:​​S464​. ​doi:10.1016/j.euroneuro.2016.09.539. 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Anderson-Schmidt H, Gade K, Malzahn D, Papiol S, Budde M, Kalman J, et al. ​Dissecting Religious Delusions In Schizophrenia: The Interplay Of Religious Activity And Polygenic Burden​. ​​European Neuropsychopharmacology. ​2017;​27​:​​S457​-S458​. ​doi:10.1016/j.euroneuro.2016.09.529. 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Budde M, Kondofersky I, Adorjan K, Aldinger F, Anderson-Schmidt H, Andlauer TF, et al. ​Integrating Polygenic Allele Burden Information And Phenomic Data To Characterize Complex Disease Trajectories In Severe Mental Illness​. ​​European Neuropsychopharmacology. ​2017;​27​:​​S406​. ​doi:10.1016/j.euroneuro.2016.09.447. 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Schulte E, Kondofersky I, Budde M, Adorjan K, Aldinger F, Anderson-Schmidt H, et al. ​Polygenic Burden Analysis of Longitudinal Clusters of Psychopathological Features In A Cross-Diagnostic Group of Individuals with Severe Mental Illness​. ​​European Neuropsychopharmacology. ​2017;​27​:​​S401​-S402​. ​doi:10.1016/j.euroneuro.2016.09.441. 
    Details  DOI 
  • 2016 Journal Article | Letter Note
    ​ ​Heilbronner U, Gade K, Herms S, Strohmaier J, Lang M, Nöthen MM, et al. ​Effect of copy number variant burden on Global Assessment of Functioning in schizophrenia​. ​​Psychiatric Genetics. ​2016;​26​(4):​​184​-185​. ​doi:10.1097/YPG.0000000000000135. 
    Details  DOI  PMID  PMC  WoS 
  • 2010 Journal Article | Letter Note
    ​ ​Gade K, Bähr M, Kermer P. ​Recurrent Episodes of Stroke-Like Symptoms Due to Accidental Intoxication With Doxepin​. ​​The Journal of Neuropsychiatry and Clinical Neurosciences. ​2010;​22​(2):​​247e23​. ​doi:10.1176/jnp.2010.22.2.247.e23 10.1176/appi.neuropsych.22.2.247-o.e23. 
    Details  DOI; DOI  PMID  PMC  WoS 

Publication List

Type

Subtype

Date issued

Author

Peer-Reviewed

Language

Fulltext

Options

Citation Style

https://publications.goettingen-research-online.de URI: /cris/rp/rp20847
ID: 0000000
PREF: vancouver TOKEN:

0

Sort

Issue Date
Title

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.